Zobrazeno 1 - 10
of 29
pro vyhledávání: '"R Deporte-Fety"'
Autor:
I. Douville, Mario Campone, F. Leger, Etienne Chatelut, M. Blasinska-Morawiec, P. Koralewski, B. Longerey, Jacques Bonneterre, R. Deporte-Fety, L. Ecochard
Publikováno v:
Cancer Chemotherapy and Pharmacology. 60:365-373
Intravenous (i.v.) vinorelbine (VRL) generally given on days 1 and 8 of an every three-week cycle in combination with paclitaxel (PTX) is an effective option for the treatment of metastatic breast cancer (MBC). In an effort to improve both patient an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6bfebd4c255c57797b9a20348c5187e
https://doi.org/10.1007/s00280-006-0375-6
https://doi.org/10.1007/s00280-006-0375-6
Autor:
J. Bonneterre, Pierre Kerbrat, Saik Urien, R. Deporte-Fety, M. Campone, Nicolas Simon, P. Fargeot, P. Fumoleau
Publikováno v:
Cancer Chemotherapy and Pharmacology. 53:233-238
To develop a population pharmacokinetic model of vinorelbine administered by short intravenous infusion in metastatic breast cancer patients.Vinorelbine was administered as infusions of 5-10 min at 15, 20 or 25 mg/m(2) to 30 patients. Blood samples w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81c7cfe8a91e91f98a2e33ac7dc01096
https://doi.org/10.1007/s00280-003-0729-2
https://doi.org/10.1007/s00280-003-0729-2
Autor:
Khaled Meflah, P. Thomare, R. Deporte-Fety, Jaafar Bennouna, Fabienne Vavasseur, F. Giacalone, Jean-Yves Douillard
Publikováno v:
Cancer Immunology, Immunotherapy. 49:56-61
Interleukin-2 (IL-2) and sodium butyrate allow rats to be cured of peritoneal carcinomatosis from colon cancer. We performed a phase I trial of IL-2 and high-dose arginine butyrate (ArgB) in patients with advanced metastatic colorectal cancer. Patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca6d38644328566c3977343fec424fbf
https://doi.org/10.1007/s002620050026
https://doi.org/10.1007/s002620050026
Publikováno v:
British Journal of Cancer
Dihydropyrimidine dehydrogenase (DPD) is the initial and rate-limiting enzyme of 5-fluorouracil (5-FU) catabolism. We report lymphocytic DPD data concerning a group of 53 patients (23 men, 30 women, mean age 58, range 36–73), treated by 5-FU-based
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ae927fca8f2062e652f4475d84b089b
https://doi.org/10.1038/sj.bjc.6690098
https://doi.org/10.1038/sj.bjc.6690098
Autor:
P. Fumoleau, R. Deporte-Fety, Pierre Kerbrat, J. Bonneterre, Saik Urien, P. Fargeot, M. Campone
Publikováno v:
Cancer chemotherapy and pharmacology. 52(2)
The pharmacokinetics of ftorafur, 5-fluorouracil (5FU) and uracil were investigated in order to built a population pharmacokinetic model for the anticancer drug UFT, administered with leucovorin and vinorelbine.A total of 31 patients with metastatic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::04e05e138f04e33dbd2779acfc59fce4
https://pubmed.ncbi.nlm.nih.gov/12768319
https://pubmed.ncbi.nlm.nih.gov/12768319
Autor:
Mario Campone, P. Fumoleau, M.-C. Bissery, Geneviève Perrocheau, N. Azli, Valérie Delecroix, A. Riva, J. P. Louboutin, R. Deporte-Fety, L. Vernillet, O. Borg-Olivier
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology. 12(7)
Summary Background and purpose: Anthracycline-containing regimens are widely used in advanced breast cancer. However, there is a need for new, non-anthracycline regimens that are active in patients for whom anthracyclines are contraindicated. The aim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::727d5468cd7f773f1645851e3cdf2dbd
https://pubmed.ncbi.nlm.nih.gov/11521794
https://pubmed.ncbi.nlm.nih.gov/11521794
Autor:
Etienne Chatelut, Ashraf Montazeri, R. Deporte-Fety, Nicolas Albin, Maude Boucaud, Pierre Canal, Brigitte Laguerre, François Lokiec, Frédéric Pinguet, Alain Goupil, Stéphane Culine, Roland Bugat
Publikováno v:
Cancer chemotherapy and pharmacology. 46(5)
The inter- and intraindividual variabilities in topotecan clearance (CL) were explored using a population pharmacokinetic approach. Total (lactone + hydroxy acid) topotecan plasma concentrations were obtained in 31 women with metastatic epithelial ov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a909cf9d4b4efa5803cba23fbd759eb1
https://pubmed.ncbi.nlm.nih.gov/11127941
https://pubmed.ncbi.nlm.nih.gov/11127941
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.